Plain-English translation of NCT07638995 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This trial is testing a new type of pacemaker called the Aveir AR, which is implanted directly in the heart without traditional wires (called leads). The study will follow 50 patients to see how well this device works, whether it causes new irregular heart rhythms, and how long the battery lasts compared to other pacemaker types.
Current pacemakers require wires that can sometimes break or cause complications. This trial exists to learn whether this new wireless pacemaker design is safer and more effective for patients who have a slow heart rhythm condition but don't yet need a dual-chamber device.
You likely qualify if…
You likely don't qualify if…
You would undergo implantation of the Aveir AR pacemaker device, a minor surgical procedure. After implantation, you would wear a heart rhythm monitor and return for follow-up visits to check how well the device is working, monitor your heart rhythm for any new problems, and track battery performance over approximately two years.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
United States